Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 23-Jul-24 4:37 PM View:  | Halozyme Therapeutics, Inc. (HALO) | 22-Jul-24 | Option Exercise | 5,000 | $22.50 | $112,500.00 | 32% 15.48K to 20.48K | |
| 23-Jul-24 4:37 PM View: | Halozyme Therapeutics, Inc. (HALO) | 22-Jul-24 | Planned Option Sale | 5,000 | $53.93 | $269,662.00 | (24%) 20.48K to 15.48K | |
| 28-Jun-24 4:06 PM View: | Halozyme Therapeutics, Inc. (HALO) | 28-Jun-24 | Option Exercise | 10,000 | $22.50 | $225,000.00 | 65% 15.48K to 25.48K | |
| 28-Jun-24 4:06 PM View: | Halozyme Therapeutics, Inc. (HALO) | 28-Jun-24 | Planned Option Sale | 10,000 | $52.04 | $520,400.00 | (39%) 25.48K to 15.48K | |
| 28-Jun-24 4:06 PM View: | Halozyme Therapeutics, Inc. (HALO) | 27-Jun-24 | Option Exercise | 10,000 | $22.50 | $225,000.00 | 65% 15.48K to 25.48K | |
| 28-Jun-24 4:06 PM View: | Halozyme Therapeutics, Inc. (HALO) | 27-Jun-24 | Planned Option Sale | 10,000 | $51.93 | $519,340.00 | (39%) 25.48K to 15.48K | |
| 28-Jun-24 4:06 PM View: | Halozyme Therapeutics, Inc. (HALO) | 26-Jun-24 | Option Exercise | 10,000 | $22.50 | $225,000.00 | 65% 15.48K to 25.48K | |
| 28-Jun-24 4:06 PM View: | Halozyme Therapeutics, Inc. (HALO) | 26-Jun-24 | Planned Option Sale | 10,000 | $51.82 | $518,200.00 | (39%) 25.48K to 15.48K | |
| 20-Feb-24 6:53 PM View: | Halozyme Therapeutics, Inc. (HALO) | 16-Feb-24 | Payment of Exercise | 5,601 | $36.10 | $202,196.00 | (27%) 21.08K to 15.48K | |
| 20-Feb-24 6:53 PM View: | Halozyme Therapeutics, Inc. (HALO) | 16-Feb-24 | Option Exercise | 10,422 | -- | -- | 98% 10.66K to 21.08K | |
| 16-Feb-24 5:41 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Feb-24 | Payment of Exercise | 686 | $35.91 | $24,634.30 | (6%) 11.35K to 10.66K | |
| 16-Feb-24 5:41 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Feb-24 | Option Exercise | 1,254 | -- | -- | 12% 10.09K to 11.35K | |
| 13-Feb-24 4:15 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Feb-24 | Payment of Exercise | 1,477 | $35.49 | $52,418.70 | (13%) 11.57K to 10.09K | |
| 13-Feb-24 4:15 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Feb-24 | Option Exercise | 2,502 | -- | -- | 28% 9.07K to 11.57K | |
| 21-Feb-23 7:00 PM View: | Halozyme Therapeutics, Inc. (HALO) | 16-Feb-23 | Option Exercise | 5,094 | -- | -- | 78% 6.5K to 11.59K | |
| 21-Feb-23 7:00 PM View: | Halozyme Therapeutics, Inc. (HALO) | 16-Feb-23 | Option Sale | 2,525 | $49.26 | $124,381.00 | (22%) 11.59K to 9.07K | |
| 17-Feb-23 6:25 AM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Feb-23 | Payment of Exercise | 621 | $49.20 | $30,553.20 | (9%) 7.12K to 6.5K | |
| 17-Feb-23 6:25 AM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Feb-23 | Option Exercise | 1,254 | -- | -- | 21% 5.86K to 7.12K | |
| 14-Feb-23 5:21 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Feb-23 | Payment of Exercise | 681 | $48.92 | $33,314.50 | (10%) 6.54K to 5.86K | |
| 14-Feb-23 5:21 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Feb-23 | Option Exercise | 1,389 | -- | -- | 27% 5.16K to 6.54K | |
| 14-Feb-23 5:21 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Feb-23 | Payment of Exercise | 1,392 | $48.92 | $68,096.60 | (21%) 6.55K to 5.16K | |
| 14-Feb-23 5:21 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Feb-23 | Option Exercise | 2,503 | -- | -- | 62% 4.04K to 6.55K | |
| 16-Nov-22 7:51 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Nov-22 | Private Sale | 5,000 | $53.81 | $269,053.00 | (55%) 9.04K to 4.04K | |
| 17-Feb-22 6:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Feb-22 | Payment of Exercise | 433 | $34.43 | $14,908.20 | (5%) 9.48K to 9.04K | |
| 17-Feb-22 6:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Feb-22 | Option Exercise | 1,255 | -- | -- | 15% 8.22K to 9.48K | |
| 14-Feb-22 7:28 PM View: | Halozyme Therapeutics, Inc. (HALO) | 14-Feb-22 | Payment of Exercise | 427 | $33.64 | $14,364.30 | (5%) 8.65K to 8.22K | |
| 14-Feb-22 7:28 PM View: | Halozyme Therapeutics, Inc. (HALO) | 14-Feb-22 | Option Exercise | 1,256 | -- | -- | 17% 7.39K to 8.65K | |
| 14-Feb-22 7:28 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Feb-22 | Payment of Exercise | 506 | $34.20 | $17,305.20 | (6%) 7.9K to 7.39K | |
| 14-Feb-22 7:28 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Feb-22 | Option Exercise | 1,389 | -- | -- | 21% 6.51K to 7.9K | |
| 14-Feb-22 7:28 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Feb-22 | Payment of Exercise | 1,025 | $34.94 | $35,813.50 | (14%) 7.54K to 6.51K | |
| 14-Feb-22 7:28 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Feb-22 | Option Exercise | 2,503 | -- | -- | 50% 5.03K to 7.54K |